Orelabrutinib versus chemoimmunotherapy in treatment-naïve chronic…
Orelabrutinib offers chronic lymphocytic leukemia patients a gentler first-line treatment option with stronger disease control than older chemotherapy approaches.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Treatment of Progressive Multifocal Leukoencephalopathy with…
Infusions of specially trained immune cells achieved lasting remission in over half of progressive multifocal leukoencephalopathy patients, a previously untreatable brain infection.
ctDNA-guided treatment de-escalation and comprehensive biomarker framework for CRC adjuvant therapyBiomarker-Guided Adjuvant Therapy in Stage II/III Colon Cancer
Personalizing colon cancer treatment using tumor biomarkers and blood tests helps doctors spare patients from harsh chemotherapy while maintaining cure rates.
Phase IIIb real-world extension of durvalumab+gemcitabine combinations in advanced BTCDurvalumab with gemcitabine-based chemotherapy regimens in advanced…
Combining immunotherapy with standard chemotherapy remains safely effective for advanced bile duct cancer across different drug combinations in real-world settings.
NONEJoint longitudinal trajectories of the triglyceride-glucose index…
Tracking weight and blood sugar patterns together pinpoints adults at dramatically higher heart disease risk, enabling earlier intervention.